Pfizer earnings and revenue top expectations despite Covid vaccine sales decline

Pfizer topped analysts' expectations with its first-quarter earnings report, despite a sales decline driven by the lower demand for the company's Covid vaccine.

from Health and Science https://ift.tt/wl7LVzi
https://ift.tt/OV4e7WT
https://ift.tt/sJgqbw3